EMA Authorised: Intrarosa (prasterone) — Endoceutics S.A.

View source ↗

Summary

Intrarosa (prasterone) has been authorised for use in the European Union for postmenopausal treatment options by Endoceutics S.A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopause

Drugs mentioned

• Intrarosa (prasterone)

Snippet

Status: Authorised. Therapeutic area: Postmenopause. MAH: Endoceutics S.A.. Decision date: 20/07/2026